Sima P. Porten

44.6k total citations · 3 hit papers
137 papers, 4.3k citations indexed

About

Sima P. Porten is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sima P. Porten has authored 137 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Surgery, 31 papers in Oncology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sima P. Porten's work include Bladder and Urothelial Cancer Treatments (100 papers), Urinary and Genital Oncology Studies (63 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Sima P. Porten is often cited by papers focused on Bladder and Urothelial Cancer Treatments (100 papers), Urinary and Genital Oncology Studies (63 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Sima P. Porten collaborates with scholars based in United States, Canada and United Kingdom. Sima P. Porten's co-authors include Maxwell V. Meng, Colin P. Dinney, Arlene O. Siefker‐Radtke, David J. McConkey, Bogdan Czerniak, Daniel Willis, Peter R. Carroll, Matthew R. Cooperberg, Woonyoung Choi and Shanna Pretzsch and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sima P. Porten

127 papers receiving 4.3k citations

Hit Papers

Identification of Distinc... 2014 2026 2018 2022 2014 2020 2022 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
    2014 1.2k citations Woonyoung Choi, Sima P. Porten et al. Cancer Cell profile →
  2. Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
    2020 464 citations Serena S. Kwek, Tony Li et al. profile →
  3. Epidemiology, Screening, and Prevention of Bladder Cancer
    2022 159 citations Sima P. Porten, Sarah P. Psutka et al. European Urology Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sima P. Porten United States 28 2.9k 1.4k 1.2k 1.0k 559 137 4.3k
Évanguelos Xylinas France 40 4.2k 1.5× 1.8k 1.3× 1.2k 1.1× 810 0.8× 1.1k 2.1× 227 5.7k
Theresa M. Koppie United States 32 2.4k 0.8× 1.3k 0.9× 909 0.8× 1.2k 1.2× 723 1.3× 71 4.2k
C.C. Abbou France 40 2.3k 0.8× 2.5k 1.8× 678 0.6× 2.0k 2.0× 521 0.9× 139 5.0k
Christian Schwentner Germany 30 1.6k 0.6× 869 0.6× 557 0.5× 731 0.7× 1.2k 2.1× 208 3.3k
J.A. Witjes Netherlands 35 2.3k 0.8× 844 0.6× 698 0.6× 982 1.0× 677 1.2× 152 4.0k
Luis Martínez‐Piñeiro Spain 26 2.3k 0.8× 741 0.5× 451 0.4× 529 0.5× 1.1k 1.9× 161 3.5k
G. Pignot France 26 1.4k 0.5× 992 0.7× 535 0.5× 773 0.8× 386 0.7× 168 2.6k
Thomas L. Jang United States 22 637 0.2× 1.4k 1.0× 579 0.5× 979 1.0× 282 0.5× 120 2.5k
Shingo Hatakeyama Japan 26 675 0.2× 842 0.6× 473 0.4× 961 1.0× 322 0.6× 188 2.6k
Wei Phin Tan United States 28 680 0.2× 892 0.6× 1.2k 1.0× 926 0.9× 176 0.3× 128 3.0k

Countries citing papers authored by Sima P. Porten

Since Specialization
Citations

This map shows the geographic impact of Sima P. Porten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sima P. Porten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sima P. Porten more than expected).

Fields of papers citing papers by Sima P. Porten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sima P. Porten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sima P. Porten. The network helps show where Sima P. Porten may publish in the future.

Co-authorship network of co-authors of Sima P. Porten

This figure shows the co-authorship network connecting the top 25 collaborators of Sima P. Porten. A scholar is included among the top collaborators of Sima P. Porten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sima P. Porten. Sima P. Porten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Psutka, Sarah P., Sima P. Porten, Kristen R. Scarpato, et al.. (2025). Expanded access program of cretostimogene grenadenorepvec in patients with non-muscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin.. Journal of Clinical Oncology. 43(5_suppl). 1 indexed citations
2.
3.
4.
Plets, Melissa, Peter C. Black, Parminder Singh, et al.. (2024). Correlation of urinary comprehensive genomic profile with risk of recurrence of BCG-unresponsive non-muscle invasive bladder cancer treated with atezolizumab in SWOG S1605.. Journal of Clinical Oncology. 42(4_suppl). 529–529.
5.
Black, Peter C., Catherine M. Tangen, Parminder Singh, et al.. (2023). Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605. European Urology. 84(6). 536–544. 48 indexed citations
6.
Lotan, Yair, Daniel A. Barocas, Sam S. Chang, et al.. (2023). Commentary on Novitas LCD. Bladder Cancer. 9(4). 305–312. 1 indexed citations
7.
Chappidi, Meera R., et al.. (2023). Readmissions trends following radical cystectomy for bladder cancer unchanged in the era of enhanced recovery after surgery (ERAS) protocols. Urologic Oncology Seminars and Original Investigations. 41(8). 355.e19–355.e28. 3 indexed citations
8.
Chou, Jonathan, Martin Sjöström, Emily A. Egusa, et al.. (2022). TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells. European Urology Oncology. 5(6). 714–718. 56 indexed citations
9.
Chu, Carissa, Martin Sjöström, Emily A. Egusa, et al.. (2021). Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin. Clinical Cancer Research. 27(18). 5123–5130. 101 indexed citations
10.
Mokkapati, Sharada, Sima P. Porten, Vikram M. Narayan, et al.. (2020). TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Molecular Cancer Research. 18(6). 811–821. 6 indexed citations
11.
Chu, Carissa, Tracy Kuo Lin, Candy Tsourounis, et al.. (2020). Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 149. 168–173. 8 indexed citations
12.
Kates, Max, Andrés Matoso, Woonyoung Choi, et al.. (2019). Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials. Clinical Cancer Research. 26(4). 882–891. 109 indexed citations
13.
Graff, Rebecca E., et al.. (2019). Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions. Bladder Cancer. 6(1). 9–23. 12 indexed citations
14.
15.
Choi, Woonyoung, Sima P. Porten, Seungchan Kim, et al.. (2014). Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy. Cancer Cell. 25(2). 152–165. 1185 indexed citations breakdown →
16.
Zaid, Uwais B., Sima P. Porten, Nadya M. Cinman, Thomas Sanford, & Benjamin N. Breyer. (2013). Xanthogranulomatous Pyelonephritis Presenting with a Left Flank Mass. Case Reports in Medicine. 2013. 1–3. 1 indexed citations
17.
Garcia, Maurice M., Sima P. Porten, & Tom F. Lue. (2012). Commentary on refractory ischemic priapism.. PubMed Central. 1(1). 61–5. 13 indexed citations
18.
Porten, Sima P., Jared M. Whitson, Janet E. Cowan, et al.. (2011). Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance. Journal of Clinical Oncology. 29(20). 2795–2800. 149 indexed citations
19.
Cooperberg, Matthew R., Janet E. Cowan, Joan F. Hilton, et al.. (2010). Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer. Journal of Clinical Oncology. 29(2). 228–234. 219 indexed citations
20.
Eisner, Brian H., Sima P. Porten, Seth K. Bechis, & Marshall L. Stoller. (2010). The Role of Race in Determining 24-Hour Urine Composition in White and Asian/Pacific Islander Stone Formers. The Journal of Urology. 183(4). 1407–1411. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Évanguelos Xylinas Breakdown of academic impact, for papers by Theresa M. Koppie Breakdown of academic impact, for papers by C.C. Abbou Breakdown of academic impact, for papers by Christian Schwentner Breakdown of academic impact, for papers by J.A. Witjes Breakdown of academic impact, for papers by Luis Martínez‐Piñeiro Breakdown of academic impact, for papers by G. Pignot Breakdown of academic impact, for papers by Thomas L. Jang Breakdown of academic impact, for papers by Shingo Hatakeyama Breakdown of academic impact, for papers by Wei Phin Tan
Rankless by CCL
2026